Apheresis Equipment Market By Procedure (Plasmapheresis, LDL-Apheresis, Plateletpheresis, Leukapheresis, Photophereis, Erythrocytapheresis), By Products & Technology (Apheresis Devices, Disposable Kits, Membrane Filtration, Centrifugation), By Applications (Renal, Neurology, Hematology) - Growth, Future Prospects And Competitive Analysis, 2016 - 2023

The rising incidence of hematological disorders has led to an increase in demand for platelets and plasma products for efficient treatment and an improvement in survival rates. The apheresis equipment market is expected to be driven by growth in the incidence of blood disorders and technological innovations in the nature and efficiency of apheresis equipment. Researchers, healthcare practitioners, and device manufacturers worldwide are therefore introducing solutions that demand minimal human intervention and allow agility to the apheresis process.

For the purpose of this study, the global apheresis equipment market was studied for product type, application, technology, procedure type, and geographical distribution. Based on product types, this market is categorized into apheresis device and disposable kit segments. Membrane filtration and centrifugation are the two technologies adopted for performing apheresis. Apheresis finds major adoption in renal, neurology, hematology, and other such applications.

Based on procedure types, the global apheresis market is segmented into major procedures, namely, plasmapheresis, LDL-apheresis, plateletpheresis, leukapheresis, photopheresis, erythrocytapheresis, and others. Market size and forecast for each of these segments for the period 2013–2023, along with their respective CAGRs for the period 2016–2023, are provided in this study while analyzing the major market developments, commercial events, product positioning, and player movements.

Geographically, the global apheresis equipment market is studied for the following regional markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • Rest of Asia Pacific
  • Middle East and Africa
  • Latin America

The market size and forecast for these regional and country-level markets are presented in this study for the period 2013–2023. Market growth rates for the forecast period 2016–2023 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global apheresis equipment market. Tools such as market positioning of key players, Porter’s five forces analysis, and attractive investment propositions provide the reader with insights into the competitive scenario of the global apheresis equipment market. This report concludes with a company profiles section that highlights major information about the key players engaged in the development, manufacture, and sales of apheresis equipment.

Based on procedure types, the apheresis equipment market is segmented into:

  1. Plasmapheresis
  2. LDL-apheresis
  3. Plateletpheresis
  4. Leukapheresis
  5. Photopheresis
  6. Erythrocytapheresis
  7. Others

Plasmapheresis accounts for the largest share of the apheresis equipment market. This procedure is used to segregate plasma from other blood cells. Growing demand for plasma products is the most significant driver for the progress of the plasmapheresis market. Plasmapheresis was first developed by Grifols in 1951. Bleeding and clotting disorders, cardiovascular diseases, and burn injuries are the chief application areas of plasmapheresis. Drugs based on plasma products are also administered to patients with a compromised or weak immune system. The growing incidence of hematological disorders is perpetually growing, thus giving rise to a demand for plasma products and acting as a primary growth driver.

Extracorporeal photopheresis, or photopheresis, is a form of leukapheresis with an additional stage of photo treatment. Photopheresis is approved by the FDA for the treatment of cutaneous T-cell lymphoma and is also used for treating solid organ transplant rejection, type 1 diabetes, scleroderma, lichen planus, atopic dermatitis, and pemphigus Vulgaris. On the basis of the growing prevalence of these diseases, the demand for both open and closed photopheresis systems is on the rise, and this growth will be witnessed throughout the forecast period.

Based on the type of products, the global apheresis equipment market is segmented as follows:

  • Apheresis Devices
  • Apheresis Disposable Kits
  • Moreover, membrane filtration and centrifugation are the two technologies used for performing the apheresis procedure.

Apheresis disposable kits are the largest segment in the total apheresis equipment market. High purchase rates of disposable kits due to high usage volumes, coupled with the ever-growing demand for apheresis procedures, drive the growth of this segment. Filters, tubes, and other such products constitute the assembly of disposable kits. In order to curb the risk of infection, single-use products are in high demand, where single-cycle procedures consume multiple disposable parts.

Such intensive consumption of disposables is responsible for the larger revenue and volume share of the disposable kit segment. The currently available apheresis devices include collection systems, separator units, data management systems, and others. Modern apheresis machines allow for quick turnaround and safety from infections. The demand for apheresis devices is burgeoning in emerging markets such as Asia Pacific and Latin America due to the rapid development of healthcare infrastructure and the growing demand for apheresis procedures.Apheresis procedures find major applications in hematology, renal, neurology, and other treatment areas.

Neurology is the largest segment for apheresis equipment. The increasing prevalence of neurological diseases such as myasthenia gravis and multiple sclerosis is a chief factor contributing to the dominance of this segment. Perpetual widening of the application of apheresis and growth in R&D efforts aimed at introducing novel products in the market will further boost the market growth. Therapeutic plasma exchange is a crucial treatment for treating myasthenia gravis, Guillain-Barre syndrome, multiple sclerosis, or chronic inflammatory demyelinating polyneuropathy.

The increasing prevalence of such diseases and the proven efficiency of apheresis in treating such conditions are major drivers of this application segment. The burden of sickle cell disease is phenomenally high. Red blood cell transfusion is used as an ideal treatment for sickle cell disease, which is a sub-type of therapeutic hemapheresis. Therapeutic plasma exchange, leukapheresis, photopheresis, and plateletpheresis are also becoming popular for treating hematological diseases.

For the purpose of this study, the global apheresis equipment market is categorized as follows:

  • North America (U.S. and Canada)
  • Europe (Germany, U.K., and the Rest of Europe)
  • Asia Pacific (Japan, China, and the Rest of Asia Pacific)
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

North America held over 45% of the global apheresis equipment market in 2015. Well-developed healthcare infrastructure, high awareness among patients and caregivers, and favorable reimbursement are the key drivers of this market. Centrifugation apheresis technology is anticipated to be in high demand in the North American market during the forecast period. The increasing incidence of hematological and neurological disorders in Europe that demand an apheresis procedure for treatment will drive the European apheresis equipment market.

Additionally, Asia-Pacific is anticipated to be the fastest-growing market for apheresis equipment during the forecast period. The increasing prevalence of blood disorders that demand treatment with platelets and plasma products in emerging markets such as China, Japan, Australia, Korea, and India is a key market driver in the Asia-Pacific market. The rapid development of healthcare infrastructure and improving awareness in the general population will additionally contribute to the demand for apheresis and hence apheresis equipment in the region.

Frequently Asked Questions:


The market for Apheresis Equipment Market is expected to reach USD 3,002.2 Bn By 2023.

The Apheresis Equipment Market is expected to see significant CAGR growth over the coming years, at 6.9%.

The report is forecasted from 2016 – 2023.

The base year of this report is 2015.

Haemonetics Corporation, Terumo BCT, Inc., HemaCare Corporation, Asahi Kasei Kuraray Medical Co., Ltd., Fenwal, Inc.,are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Aug 2016
Category:  Medical Devices
Report ID:   58047
Report Format:   PDF
Pages:   120
Rating:    4.3 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support